← Leaderboards
Tatiana Kisseleva
University Of Southern California
$14,632,761
Attributed
$20,726,547
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,726,547 · 11
By mechanism
R01$12,315,753 · 4
U01$7,148,604 · 3
P30$663,120 · 2
P50$405,320 · 1
R56$193,750 · 1
Top collaborators
- David A Brenner6 shared
- Michael Karin5 shared
- Rohit Loomba5 shared
- Derek Mann5 shared
- Sheldon Robert Morris5 shared
- Hidekazu Tsukamoto5 shared
Others in their field
Top investigators on “Liver Fibrosis”
- Russell E Ware · Duke University$24,864,158
- Anna Mae Elizabeth Diehl · Johns Hopkins University$21,060,994
- Phyllis C Tien · University Of California San Francisco$20,924,327
- Hidekazu Tsukamoto · Va Greater Los Angeles Healthcare System$20,691,236
- John C Magee · University Of Michigan At Ann Arbor$20,428,942
- Scott Laurence Friedman · Mount Sinai School Of Medicine Of Nyu$18,815,021
Research focus
Liver FibrosisMediatingCellsLiverFibrosisResponseMyofibroblastHepatic Stellate CellCirrhosisGenesSignal TransductionLiver InjuryIn VitroCollagen Type IPathogenesisIn VivoInsightMouse ModelBaseTranscriptome SequencingInjuryProductionInjuredTranslating
Grant awards (49)
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH$625,765
R01 · FY2025 · DK · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$486,640
R01 · FY2025 · DK · contact PI
The role of IL-17 signaling in alcohol-induced HCC$464,520
R01 · FY2025 · AA · contact PI
Southern California Research Center for ALPD and Cirrhosis$234,680
P50 · FY2025 · AA · contact PI
Preclinical Models Core$192,144
P30 · FY2025 · DK · contact PI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease$711,945
U01 · FY2024 · AA
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH$600,735
R01 · FY2024 · DK · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$467,173
R01 · FY2024 · DK · contact PI
The role of IL-17 signaling in alcohol-induced HCC$464,520
R01 · FY2024 · AA · contact PI
Preclinical Models Core$206,644
P30 · FY2024 · DK · contact PI
Southern California Research Center for ALPD and Cirrhosis$170,640
P50 · FY2024 · AA · contact PI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease$742,984
U01 · FY2023 · AA
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH$625,765
R01 · FY2023 · DK · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$486,640
R01 · FY2023 · DK · contact PI
The role of IL-17 signaling in alcohol-induced HCC$464,520
R01 · FY2023 · AA · contact PI
Preclinical Models Core$264,332
P30 · FY2023 · DK · contact PI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease$699,515
U01 · FY2022 · AA
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH$625,765
R01 · FY2022 · DK · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$486,640
R01 · FY2022 · DK · contact PI
The role of IL-17 signaling in alcohol-induced HCC$464,520
R01 · FY2022 · AA · contact PI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease$781,354
U01 · FY2021 · AA
Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH$625,765
R01 · FY2021 · DK · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$486,640
R01 · FY2021 · DK · contact PI
The role of IL-17 signaling in alcohol-induced HCC$464,520
R01 · FY2021 · AA · contact PI
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease$782,852
U01 · FY2020 · AA
Fibrocytes regulate liver fibrosis$348,750
R01 · FY2020 · DK · contact PI
Fibrocytes regulate liver fibrosis$348,750
R01 · FY2019 · DK · contact PI
Epigenetic Regulation of Alcoholic Liver Fibrosis$330,525
U01 · FY2019 · AA
The Role of IL-17 in Alcoholic Liver Disease and Cancer$353,250
U01 · FY2018 · AA · contact PI
Fibrocytes regulate liver fibrosis$348,750
R01 · FY2018 · DK · contact PI
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis$337,125
R01 · FY2018 · DK · contact PI
Epigenetic Regulation of Alcoholic Liver Fibrosis$330,525
U01 · FY2018 · AA
The Role of IL-17 in Alcoholic Liver Disease and Cancer$353,250
U01 · FY2017 · AA · contact PI
Fibrocytes regulate liver fibrosis$348,750
R01 · FY2017 · DK · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$348,750
R01 · FY2017 · DK · contact PI
Epigenetic Regulation of Alcoholic Liver Fibrosis$345,150
U01 · FY2017 · AA
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis$337,125
R01 · FY2017 · DK · contact PI
The Role of IL-17 in Alcoholic Liver Disease and Cancer$353,250
U01 · FY2016 · AA · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$348,750
R01 · FY2016 · DK · contact PI
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis$337,125
R01 · FY2016 · DK · contact PI
Epigenetic Regulation of Alcoholic Liver Fibrosis$319,950
U01 · FY2016 · AA
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$348,750
R01 · FY2015 · DK · contact PI
The Role of IL-17 in Alcoholic Liver Disease and Cancer$342,652
U01 · FY2015 · AA · contact PI
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis$337,125
R01 · FY2015 · DK · contact PI
Epigenetic Regulation of Alcoholic Liver Fibrosis$334,627
U01 · FY2015 · AA
The Role of IL-17 in Alcoholic Liver Disease and Cancer$366,775
U01 · FY2014 · AA · contact PI
The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis$348,750
R01 · FY2014 · DK · contact PI
Inactivation of Hepatic Stellate Cells During Reversal of Liver Fibrosis$337,125
R01 · FY2014 · DK · contact PI
The Role of Fibrocytes in Liver Fibrosis$193,750
R56 · FY2012 · DK · contact PI